End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
14,130 KRW | +7.62% |
|
-1.19% | +8.69% |
2023 | Biodyne Co., Ltd.(KOSDAQ:A314930) added to S&P Global BMI Index | CI |
2023 | Biodyne Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
Business Summary
Sales per Business
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Cancer Diagnosis Solutions - Merchandise
100.0
%
| - | - | 4,089 | 100.0 % | - |
Sales per region
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
South Korea
30.1
%
| 1,186 | 9.7 % | 1,229 | 30.1 % | +3.60% |
Japan
28.8
%
| 1,193 | 9.8 % | 1,177 | 28.8 % | -1.31% |
Europe
28.0
%
| 1,065 | 8.7 % | 1,143 | 28.0 % | +7.34% |
Others
13.2
%
| 8,766 | 71.8 % | 539 | 13.2 % | -93.85% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Wook-Bin Im
CEO | Chief Executive Officer | 50 | - |
Gwang-Sik Shin
DFI | Director of Finance/CFO | 51 | - |
Ja-Min Lee
CTO | Chief Tech/Sci/R&D Officer | 49 | - |
Woo-Seok Jo
COO | Chief Operating Officer | 53 | - |
Yong-Jin Jung
AUD | Comptroller/Controller/Auditor | 49 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Jong-Hoon Lee
BRD | Director/Board Member | 40 | - |
Wook-Bin Im
CEO | Chief Executive Officer | 50 | - |
Gwang-Sik Shin
DFI | Director of Finance/CFO | 51 | - |
Woo-Seok Jo
COO | Chief Operating Officer | 53 | - |
Ja-Min Lee
CTO | Chief Tech/Sci/R&D Officer | 49 | - |
Jae-Man Bae
BRD | Director/Board Member | 52 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 29,764,103 | 13,350,575 ( 44.85 %) | 287,343 ( 0.9654 %) | 44.85 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
BIODYNE CO., LTD. 4.65% | 1,436,715 | 4.65% | 9,567,373 $ |
Company contact information
![address Biodyne Co., Ltd.(A314930)](https://cdn.zonebourse.com/static/address/120976884.png)
Sector
Sales per Business
Sales per region
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+8.69% | 28Cr | |
-8.90% | 1.15TCr | |
-12.79% | 732.6Cr | |
+26.65% | 567.74Cr | |
-17.87% | 371.16Cr | |
+7.41% | 249.28Cr | |
-65.15% | 234.51Cr | |
+28.63% | 223.19Cr | |
-11.56% | 221.77Cr | |
-14.32% | 160.8Cr |
- Stock Market
- Equities
- A314930 Stock
- Company Biodyne Co., Ltd.